| __timestamp | AbbVie Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 8494000000 |
| Thursday, January 1, 2015 | 4285000000 | 9046000000 |
| Friday, January 1, 2016 | 4366000000 | 9095000000 |
| Sunday, January 1, 2017 | 4982000000 | 10554000000 |
| Monday, January 1, 2018 | 10329000000 | 10775000000 |
| Tuesday, January 1, 2019 | 6407000000 | 11355000000 |
| Wednesday, January 1, 2020 | 6557000000 | 12340000000 |
| Friday, January 1, 2021 | 7084000000 | 14277000000 |
| Saturday, January 1, 2022 | 6510000000 | 14135000000 |
| Sunday, January 1, 2023 | 8453000000 | 15048000000 |
| Monday, January 1, 2024 | 0 | 17232000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Johnson & Johnson and AbbVie Inc. have been at the forefront of this race. From 2014 to 2023, Johnson & Johnson consistently outpaced AbbVie, with R&D expenses peaking at approximately $15 billion in 2023, a 77% increase from 2014. Meanwhile, AbbVie saw a significant surge in 2018, with a 134% increase from 2014, reaching its highest R&D expenditure of around $10 billion. This trend underscores the strategic emphasis both companies place on innovation, with Johnson & Johnson maintaining a steady lead. As the pharmaceutical industry continues to face new challenges, these investments highlight the critical role of R&D in driving future growth and breakthroughs.
Johnson & Johnson vs AstraZeneca PLC: Strategic Focus on R&D Spending
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Johnson & Johnson vs Gilead Sciences, Inc.
Analyzing R&D Budgets: Johnson & Johnson vs Madrigal Pharmaceuticals, Inc.
Johnson & Johnson or BioMarin Pharmaceutical Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Johnson & Johnson vs Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Agios Pharmaceuticals, Inc.
Johnson & Johnson or MiMedx Group, Inc.: Who Invests More in Innovation?
AbbVie Inc. or Bristol-Myers Squibb Company: Who Invests More in Innovation?
Comparing Innovation Spending: AbbVie Inc. and Takeda Pharmaceutical Company Limited
Research and Development Expenses Breakdown: AbbVie Inc. vs Biogen Inc.
Analyzing R&D Budgets: AbbVie Inc. vs CRISPR Therapeutics AG